All In Biotech

Drug Trial Radar · NCT06713135

A Study on Safety and Effectiveness of Long-term Treatment With Vamorolone in Boys With Duchenne Muscular Dystrophy

An Open-label Study to Collect Safety and Effectiveness Information on Long-term Treatment With Vamorolone in Boys With Duchenne Muscular Dystrophy Who Have Completed Prior Studies With Vamorolone

Last checked: Nov 19, 2026Latest source record: Apr 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

80

Planned (sponsor's estimate)

Start

Nov 10, 2024

Primary completion

Sep 2028

Study completion Sep 2028

Sponsor

Lead sponsor
Santhera PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Dec 3, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Male only
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aims to assess safety and effectivness of long-term treatment with vamorolone in boys with Duchenne Muscular Dystrophy (DMD) who have completed prior studies with vamorolone.

Conditions

  • Duchenne Muscular Dystrophy

Interventions

  • vamorolone 40 mg/mL oral suspensionDrug

    Vamorolone is administered at a dose range between 2 mg/kg/day and 6 mg/kg/day for boys weighing \<40 kg. For boys weighing 40 kg or above, the dose range will be 80 mg to 240 mg once daily. Doses can be adjusted within the dose range as determined by the Investigator based on tolerability. The highest tolerated dose should be used.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of vertebral fractures per 1000 person-years based on X-ray central reading.Time frame: At Enrolment and every 2 years during a Full visit

Locations

18 sites in 9 countries. Site status is shown where the registry gives one.

  • UZ Gent (Universitair Ziekenhuis Gent)

    Ghent, Belgium

  • UZ Leuven (Universitair Ziekenhuis Leuven)

    Leuven, Belgium

  • University Hospital Brno

    Brno, Czechia

  • Fakultni Nemocnice Motol

    Prague, Czechia

  • Children's Hospital Agia Sofia

    Athens, Greece

  • Children's Health Ireland at Tallaght, Tallaght University Hospital

    Dublin, Ireland

  • Schneider Children's Medical Center

    Petah Tikva, Israel

  • Leiden University Medical Center

    Leiden, Netherlands

  • Radboud University Nijmegen

    Nijmegen, Netherlands

  • Te Wao Nui - Child Health Service, Wellington Hospital

    Wellington, New Zealand

  • Hospital Universitario Puerta de Hierro Majadahonda

    Madrid, Spain

  • Hospital Universitario y Politecnico de La Fe

    Valencia, Spain

  • University Hospitals Birmingham NHS Foundation Trust

    Birmingham, United Kingdom

  • Great Ormond Street Hospital for Children NHS Foundation Trust

    London, United Kingdom

  • The John Walton Muscular Dystrophy Research Centre

    Newcastle, United Kingdom

  • Queen Elizabeth University Hospital

    Glasgow, Lanarkshire, United Kingdom

  • Alder Hey Children's Hospital

    Liverpool, Merseyside, United Kingdom

  • Leeds Teaching Hospitals NHS Trust

    Leeds, West Yorkshire, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.